Total Cost of Revenue
Gilead Sciences Total Cost of Revenue increased by 3.5% to $1.62B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $1.58B to $1.62B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a -1.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase relative to revenue may indicate rising component costs or manufacturing inefficiencies, whereas a decrease suggests better economies of scale.
Detailed definition
The direct costs attributable to the production of the goods sold and the delivery of services. This typically encompass...
Peer comparison
In the consumer electronics industry, this is often compared against revenue to determine the efficiency of the supply chain.
is_total_cost_of_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.39B | $1.22B | $2.63B | $1.42B | $1.44B | $1.40B | $1.40B | $1.40B | $1.44B | $1.57B | $2.09B | $1.55B | $1.54B | $1.57B | $1.58B | $1.54B | $1.50B | $1.57B | $1.62B |
| QoQ Change | — | -12.0% | +114.8% | -45.8% | +1.3% | -3.3% | +0.1% | +0.4% | +2.9% | +8.5% | +33.5% | -25.7% | -0.5% | +1.9% | +0.4% | -2.6% | -2.5% | +4.5% | +3.5% |
| YoY Change | — | — | — | — | +3.7% | +14.1% | -46.9% | -1.6% | +0.0% | +12.2% | +49.7% | +10.8% | +7.1% | +0.6% | -24.4% | -0.8% | -2.8% | -0.3% | +2.7% |
Total Cost of Revenue at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's total cost of revenue?
- Gilead Sciences (GILD) reported total cost of revenue of $1.62B in Q4 2025.
- How has Gilead Sciences's total cost of revenue changed year-over-year?
- Gilead Sciences's total cost of revenue increased by 2.7% year-over-year, from $1.58B to $1.62B.
- What is the long-term trend for Gilead Sciences's total cost of revenue?
- Over 4 years (2021 to 2025), Gilead Sciences's total cost of revenue has grown at a -1.4% compound annual growth rate (CAGR), from $6.60B to $6.23B.
- What does total cost of revenue mean?
- The direct cost of making the products or providing the services that a company sells.